Botanical ingredients provider Activ'Inside has established a US subsidiary to drive its growth in the key North American market.
By bolstering its business presence in the region, Activ'Inside hopes to ensure faster market access to its premium ingredients for its customers throughout the US.
Activ'Inside Incorporated builds on the company's well-established divisions within the European and Asian markets, and was created to improve logistical efficiency and expedite ingredient market entry.
The US is currently the world's largest dietary supplement market — estimated to be worth around $53.58bn in 2023.
“We decided to establish a US subsidiary as we want to boost our global growth," commented Vincent Bellette, Deputy CEO of Activ'Inside.
“By maintaining local product inventory and a dedicated sales force, we can reduce lead times and provide our customers with an enhanced service. This enables us to introduce our scientifically validated ingredients to the US market more efficiently than ever before.”
The creation of Activ'Inside Incorporated will also allow the company to better provide its flagship saffron extract, Safr'Inside, to clients across the region.
The nutraceutical has already earned a US patent, and has been proven to support mental health through six methods of action — including stress reduction, sleep quality and emotional wellbeing.
It has also been proven to modulate serotonin levels.
“Activ'Inside has always been a solution provider, and this expansion allows us to be closer to our US clients. By understanding their specific needs, we can offer adaptable, potentially proprietary solutions that set them apart in the market,” concludes Benoit Lemaire, CEO of Activ'Inside.
